FDA Approves First Subcutaneous Infliximab for Maintenance Therapy in UC and Crohn Disease

Press/Media

Period	23 Oct 2023

Media coverage

Title	FDA Approves First Subcutaneous Infliximab for Maintenance Therapy in UC and Crohn Disease
Media name/outlet	HCPLive
Country/Territory	United States
Date	23/10/23
URL	ct.moreover.com/?a=52138055770&p=1gw&v=1&x=cELCJf_GuPp-iORuelS4qw
Persons	Jean-Frédéric Colombel

Title	FDA Approves First Subcutaneous Infliximab for Maintenance Therapy in UC and Crohn Disease
Media name/outlet	Consultant Live
Country/Territory	United States
Date	23/10/23
URL	ct.moreover.com/?a=52138103341&p=1gw&v=1&x=Y-QbeZUuKx2FUEUKPXab6A
Persons	Jean-Frédéric Colombel